BAYER CROP SCIENCE, INC. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for BAYER CROP SCIENCE, INC.

Sort by

Viewing results 1‒25 of 299

News updates from March 5: China targets 5% GDP growth in 2024, Gold and Bitcoin hit record highs
Bayer postpones decision on break-up
...German drugs and crop science conglomerate Bayer has postponed a decision on whether to break itself up, as it launches a €2bn cost-cutting plan and promises to bring down debt....
March 5, 2024
Bayer AG
Bayer CEO calls German group ‘badly broken’ as he holds off split
...He added that the underlying operative problems in the pharma and crop science businesses needed to be addressed without undue job cuts....
March 5, 2024
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News updates from November 8: Iger pledges another $2bn in Disney cost cuts, Draghi delivers downbeat EU forecast
Bayer weighs carve-out of crop science or consumer health units
...Bayer is under pressure from shareholders as it is reeling from the $63bn acquisition of US crop science giant Monsanto....
November 8, 2023
Bayer AG
Bayer slashes dividend by 95% as it steps up effort to cut debt
...The company, which has been under pressure from investors to break itself up, is still struggling with the damage from its $63bn takeover of US crop sciences group Monsanto in 2016....
February 19, 2024
News in-depthBayer AG
Bayer turns to state lobbying in battle over Roundup weedkiller
...Despite that, the company has taken steps to end the protracted crisis over Roundup, which Bayer acquired as part of its ill-fated $63bn acquisition of US crop sciences business Monsanto in 2016....
March 4, 2024
Bayer AG
Bayer shares plunge after blood-thinning drug trial halted
...from the crop sciences business....
November 20, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Bayer AG
Bayer chief blasts conglomerate’s performance as ‘unacceptable’
...Bayer also took a €4bn impairment charge on the value of its crop science assets, adding to a €2.3bn writedown in the second quarter....
November 8, 2023
The crisis in European equities
Flight risk? London listings are the most vulnerable to New York’s allure
...Activist investors want to split the group’s pharmaceuticals business from its crop science unit to optimise its valuation....
May 26, 2023
LexBayer AG
Bayer: cell therapy is a promising prescription Premium content
...Crop science is the largest part of the business and would work as a standalone. There is also a case for splitting off pharma, which would be worth about €33bn....
October 10, 2023
Bayer AG
Bayer drug setback adds to new CEO’s problems
...Last month he blasted Bayer’s performance as “unacceptable” and stressed that “all options” were on the table, including splitting the pharma unit from the crop science division....
November 23, 2023
LexBayer AG
Monsanto: Anderson must uproot Bayer’s perennial problem Premium content
...Bayer has argued that cash flow from crop science and its consumer health unit help fund its growing pharmaceuticals pipeline....
July 25, 2023
Chemicals
US lawyers keep up pressure on Bayer over Roundup
...Some investors fear that the uncertainty over Roundup’s financial burden could limit Anderson’s room for manoeuvre with regard to a potential separation of Bayer’s crop science business and its pharma unit...
August 7, 2023
The Big Read
The dubious climate gains of turning soil into a carbon sink
...Henry adds that better soil health as a result of regenerative practices, also make crops more resilient to extreme weather events....
January 23, 2024
InterviewBayer AG
New Bayer chief plans a radically different style to cut bureaucracy
...In the science fiction movie, the scientists aboard a spaceship gradually find out that the computer had taken over the mission....
June 18, 2023
Merck & Co Inc
Merck to open £1bn London research centre with plea for government support of industry
...AstraZeneca said in February it had chosen to open a $360mn factory in Ireland, rather than in the UK, because of a “discouraging tax rate”, while German drugmaker Bayer said last year that it had cut staff...
October 15, 2023
FT Live
Moral Money Summit Americas
Unlocking opportunities for a greener and fairer world
Tuesday, 15 OctoberNew York, USA
Bayer AG
Activist investor ramps up pressure on incoming Bayer boss
...It argues that this would send a “strong signal of discontinuity” for the underperforming company, which should be split into its crop science and pharmaceutical divisions....
April 20, 2023
HTSI
Exploring beauty’s biotech frontier
...Biotech beauty products are increasingly filling our bathroom cabinets; the science may have been used in a simple way for decades, but new innovations are driving considerable change....
October 24, 2023
Alice Ross
ESG gains would be few without the Magnificent Seven
...Clements thinks life science companies will bounce back next year, and is hopeful about electric vehicles and water stocks....
December 15, 2023
Bayer AG
Bayer embraces activist Ubben with place on its sustainability council
...Matthias Berninger, Bayer’s head of science and sustainability and a former politician with the German Green party, said the council has worked to improve the group’s ESG policies and wants to pioneer green...
February 26, 2023
Moral Money
Activist Jeff Ubben discovers a ‘jewel’ at Bayer Premium content
...Bayer has about €120bn in assets. If Bayer’s crop sciences division were to trade on its own, he said, it could have a valuation similar to Corteva’s....
January 11, 2023
Bayer AG
Bayer appoints Roche veteran Anderson as chief executive
...Analysts, investment bankers and activist shareholders have long argued in favour of a break-up of the German conglomerate whose two main divisions pharmaceuticals and crop science have few synergies....
February 8, 2023
LexBayer AG
Bayer: Roundup case blights crop giant’s bumper harvest Premium content
...Adjusted sales in the first nine months were up almost 17 per cent over the previous year in Bayer’s crop science division....
November 10, 2022
Bayer AG
Activist investor Jeff Ubben urges Bayer to look for external CEO
...science....
January 9, 2023
Investor activism
Investor Jeff Ubben questions ESG funds in second act as activist
...“A lot of the work that needs to be done to ‘green’ Bayer’s crop sciences business isn’t necessarily through changing the business itself, it’s through changing the perception thereof.”...
January 20, 2023
Lex is more
How investors are underpricing climate risks
...Ear for the long haul Crop science is also attracting greater political and investor attention....
August 17, 2023

Previous pagePage 1 of 12Next page